Hexylcaffeate

Hexylcaffeate

SCHEMBL7943388

CCCCCCOC(=O)C=Cc1ccc(O)c(O)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 14/20 1.00
▸ TTR P02766 4/20 0.70
▸ DPP4 P27487 1/20 0.70
▸ IAPP P10997 1/20 0.62
▸ CYP3A4 P08684 2/20 0.61
▸ ALOX15 P16050 2/20 0.61
▸ ALOX12 P18054 2/20 0.61
▸ MAPK1 P28482 2/20 0.61
▸ HSD17B10 Q99714 2/20 0.61
▸ KDM4E B2RXH2 1/20 0.61
▸ MEN1 O00255 1/20 0.61
▸ AKR1B10 O60218 1/20 0.61
▸ GMNN O75496 1/20 0.61
▸ ALDH1A1 P00352 1/20 0.61
▸ EGFR P00533 1/20 0.61
▸ LMNA P02545 1/20 0.61
▸ ESR1 P03372 1/20 0.61
▸ ERBB2 P04626 1/20 0.61
▸ LCK P06239 1/20 0.61
▸ FYN P06241 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19358970 1.00 APP (1.00) APPTTRDPP4IAPPCYP3A4
SCHEMBL19359050 1.00 APP (1.00) APPTTRDPP4IAPPCYP3A4
SCHEMBL15009234 1.00 APP (1.00) APPTTRDPP4IAPPCYP3A4
SCHEMBL19358977 1.00 APP (1.00) APPTTRDPP4IAPPCYP3A4
SCHEMBL3240552 1.00 APP (1.00) APPTTRDPP4IAPPCYP3A4
SCHEMBL19359049 1.00 APP (1.00) APPTTRDPP4IAPPCYP3A4
Hexylcaffeate SCHEMBL19358999 1.00 APP (1.00) APPTTRDPP4IAPPCYP3A4
SCHEMBL19358992 1.00 APP (1.00) APPTTRDPP4IAPPCYP3A4
SCHEMBL19358989 1.00 APP (1.00) APPTTRDPP4IAPPCYP3A4
SCHEMBL16428905 1.00 APP (1.00) APPTTRDPP4IAPPCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111296445-A Laurella solanacearum targeted nano medicament and preparation method and application thereof 江苏科技大学 2020-06-19 — — CN claimed
WO-2017161093-A1 CAFFEIC ACID DERIVATIVES AND USES THEREOF MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) 2017-09-21 — — WO claimed
EP-3713604-B1 COMPOUND FOR USE IN THE INCREASING OF MENTAL CAPABILITY LEIBNIZ INST FUER NEUROBIOLOGIE LIN STIFTUNG DES OEFFENTLICHEN RECHTS (DE) 2023-06-07 — — EP disclosed
CN-111296445-B Laurella solanacearum targeted nano medicament and preparation method and application thereof 江苏科技大学 2022-03-11 — — CN disclosed
CN-111296445-A Laurella solanacearum targeted nano medicament and preparation method and application thereof 江苏科技大学 2020-06-19 — — CN disclosed
WO-2017161093-A1 CAFFEIC ACID DERIVATIVES AND USES THEREOF MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) 2017-09-21 — — WO disclosed
US-20140127316-A1 PROPOLIS AND CAFFEIC ACID PHENETHYL ESTER AND USES THEREOF NEW YORK UNIVERSITY 2014-05-08 — — US disclosed
WO-2013012477-A1 PROPOLIS AND CAFFEIC ACID PHENETHYL ESTER AND USES THEREOF NEW YORK UNIVERSITY (US) 2013-01-24 — — WO disclosed
US-6265344-B1 WHICH IS SUITABLE FOR A FILM FOR A VIDEO PRINTER. RICOH COMPANY, LTD. (JP) 2001-07-24 — — US disclosed
US-6066311-A ESTERIFICATION OF CHLOROGENIC ACID WITH AN ESTERIFYING ENZYME. CAFFEIC ACID AND ITS DERIVATIVES, PRODUCED BY THIS METHOD, MAY BE USED IN SUNSCREEN COMPOSITIONS, THE CAFFEIC ACID AND ITS DERIVATIVES ABSORBING BOTH UVA AND UVB LIGHT. ZYLEPSIS LIMITED (GB) 2000-05-23 — — US disclosed
US-5952263-A PROTECTIVE LAYER FORMED OF A RESIN WITH MICROSCOPICALLY ROUGH SURFACE HORIZONTALLY CUT AT EQUALLY SPACED INTERVALS; HIGH TRANSPARENCY, IMAGE QUALITY WITHOUT WHITE STREAKS AND NONSTICKING TO THERMAL PRINTHEADS RICOH COMPANY, LTD. (JP) 1999-09-14 — — US disclosed
US-5935899-A PROTECTIVE LAYER COMPRISING SPHERICAL FILLER AND AN IRREGULAR SHAPED FILLER; NON-STICKING TO THERMAL HEAD, NO WHITE STRIPE, DECREASED HEAD DEFACEMENT; COMPUTERS, FACSIMILE MACHINES; LABEL PRINTERS RICOH COMPANY, LTD. (JP) 1999-08-10 — — US disclosed
US-5866507-A BLEND OF BINDER AND COLORING AGENT RICOH COMPANY, LTD. (JP) 1999-02-02 — — US disclosed
US-5792724-A HIGH TRANSMITTANCE DENSITY, EXCELLENT REPRODUCIBILITY OF FINE DOT AND HALF TONE IMAGES; MIXTURE OF BINDER RESINS WITH DIFFERENT GLASS TRANSIFION TEMPERATURES RICOH CO., LTD. (JP) 1998-08-11 — — US disclosed
EP-0764147-A1 PRODUCTION AND USES OF CAFFEIC ACID AND DERIVATIVES THEREOF ZYLEPSIS LIMITED (GB) 1997-03-26 — — EP disclosed
WO-1995033706-A1 PRODUCTION AND USES OF CAFFEIC ACID AND DERIVATIVES THEREOF ZYLEPSIS LIMITED (GB) 1995-12-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140127316-A1 PROPOLIS AND CAFFEIC ACID PHENETHYL ESTER AND USES THEREOF EP300, HDAC1, HDAC8 APP 1017/4885TTR 2988/4885DPP4 1241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback